SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-012120
Filing Date
2019-07-05
Accepted
2019-07-05 11:47:01
Documents
4
Period of Report
2019-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.06: Change in Shell Company Status
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K f8k051519a1_xynomicpharma.htm 8-K/A 270703
2 UNAUDITED FINANCIAL STATEMENTS OF XYNOMIC PHARMACEUTICALS, INC. AS OF MARCH 31, f8k051519a1ex99-2_xynomic.htm EX-99.2 228836
3 PRO FORMA FINANCIAL STATEMENTS AS OF MARCH 31, 2019, AND FOR THE THREE MONTHS EN f8k051519a1ex99-4_xynomic.htm EX-99.4 114904
4 GRAPHIC img_001.jpg GRAPHIC 146876
  Complete submission text file 0001213900-19-012120.txt   818786
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38120 | Film No.: 19943438
SIC: 2834 Pharmaceutical Preparations